Disposition of 150000 shares by Richard Mulligan of Sana Biotechnology at 4.0838 subject to Rule 16b-3
SANA Stock | USD 3.16 0.35 12.46% |
About 67 percent of all Sana Biotechnology's investors are curious in acquiring. The analysis of the overall investor sentiment regarding Sana Biotechnology suggests that a large number of traders are confidant. The current market sentiment, together with Sana Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Sana Biotechnology stock news signals to limit their universe of possible portfolio assets.
Sana |
Filed transaction by Sana Biotechnology Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Sana Biotechnology's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Sana Biotechnology's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Sana Biotechnology Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Sana Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Top Midday Gainers
recently @ finance.yahoo.com
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Sana Biotechnology Historical Investor Sentiment
Investor biases related to Sana Biotechnology's public news can be used to forecast risks associated with an investment in Sana. The trend in average sentiment can be used to explain how an investor holding Sana can time the market purely based on public headlines and social activities around Sana Biotechnology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sana Biotechnology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sana Biotechnology and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Sana Biotechnology news discussions. The higher the estimate score, the more favorable the investor's outlook on Sana Biotechnology.
Sana Biotechnology Fundamental Analysis
We analyze Sana Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sana Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sana Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Sana Biotechnology is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Sana Biotechnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sana Biotechnology stock to make a market-neutral strategy. Peer analysis of Sana Biotechnology could also be used in its relative valuation, which is a method of valuing Sana Biotechnology by comparing valuation metrics with similar companies.
Peers
Sana Biotechnology Related Equities
ZNTL | Zentalis Pharmaceuticals | 12.50 | ||||
GBIO | Generation Bio | 9.68 | ||||
LYEL | Lyell Immunopharma | 5.17 | ||||
AMLX | Amylyx Pharmaceuticals | 3.62 | ||||
OLMA | Olema Pharmaceuticals | 2.90 | ||||
XFOR | X4 Pharmaceuticals | 2.00 | ||||
GLUE | Monte Rosa | 0.89 | ||||
KYMR | Kymera Therapeutics | 0.68 | ||||
DAWN | Day One | 0.41 | ||||
APLS | Apellis Pharmaceuticals | 0.22 | ||||
TERN | Terns Pharmaceuticals | 0.49 | ||||
HOOK | Hookipa Pharma | 0.53 | ||||
CGEM | Cullinan Oncology | 0.63 | ||||
BPMC | Blueprint Medicines | 1.31 | ||||
RVMD | Revolution Medicines | 1.57 |
Complementary Tools for Sana Stock analysis
When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |